Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    NICE publishes guideline for multiple myeloma

    Author:
    HT Staff
    Publish date: February 11, 2016

    Photo courtesy of NIH The National Institute for Health and Care Excellence (NICE) has published a guideline containing recommendations for...

    • Read More

    News

    Method could improve diagnosis of platelet disorders

    Author:
    HT Staff
    Publish date: February 10, 2016

    Courtesy of Dan Cutler A proof-of-concept study suggests structured illumination microscopy (SIM) enables accurate diagnosis of Hermansky-Pudlak...

    • Read More

    News

    Gut microbiota linked to severity of malaria

    Author:
    HT Staff
    Publish date: February 10, 2016

    Microorganisms in the gut play a role in the severity of malaria, according to a study published in PNAS. Investigators examined the gut...

    • Read More

    News

    EBV-CTLs get orphan designation for EBV-PTLD

    Author:
    HT Staff
    Publish date: February 10, 2016

    among uninfected cells (blue) Image courtesy of Benjamin Chaigne-Delalande The US Food and Drug Administration (FDA) has granted orphan...

    • Read More

    News

    MF drug trials placed on partial clinical hold

    Author:
    HT Staff
    Publish date: February 9, 2016

    The US Food and Drug Administration (FDA) has placed a partial clinical hold on trials conducted under the investigational new drug (IND)...

    • Read More

    News

    Study reveals delays in emergency blood transfusions

    Author:
    HT Staff
    Publish date: February 9, 2016

    Photo courtesy of UAB Hospital A new study suggests that as few as 2% of patients with life-threatening bleeding after serious injury receive...

    • Read More

    News

    New insight into Ph-like ALL could lead to new treatment

    Author:
    HT Staff
    Publish date: February 9, 2016

    Photo courtesy of St.

    • Read More

    News

    vials and a syringe

    EMA recommends therapy for bleeding disorder

    Author:
    HT Staff
    Publish date: February 8, 2016

    The European Medicines Agency (EMA) has recommended marketing authorization for Coagadex to treat hereditary factor X deficiency, a rare bleeding...

    • Read More

    News

    Tandem HSCT regimen may cure MM

    Author:
    HT Staff
    Publish date: February 8, 2016

    Photo by Chad McNeeley Tandem autologous/allogeneic hematopoietic stem cell transplant (HSCT) may cure multiple myeloma (MM), according to a...

    • Read More

    News

    Induction ALL treatment can cause bone loss

    Author:
    HT Staff
    Publish date: February 7, 2016

    of cancellous bone Patients with acute lymphoblastic leukemia (ALL) may experience significant bone loss much earlier than previously assumed,...

    • Read More

    News

    Rivaroxaban trial results hold up, EMA says

    Author:
    HT Staff
    Publish date: February 6, 2016

    The European Medicines Agency (EMA) has concluded that a defect discovered in a system used to measure international normalized ratios (INRs) in...

    • Read More

    News

    New assay detects persistent CML better, team says

    Author:
    HT Staff
    Publish date: February 5, 2016

    A new assay is more accurate than the current gold standard for detecting residual disease in patients with chronic myeloid leukemia (CML),...

    • Read More

    News

    Brazil reports Zika transmission via transfusion

    Author:
    HT Staff
    Publish date: February 5, 2016

    Photo by Marja Helander Health officials in Campinas, Brazil, have reported 2 cases of the Zika virus that were likely transmitted through blood...

    • Read More

    News

    FDA approves drug for patients receiving MEC

    Author:
    HT Staff
    Publish date: February 5, 2016

    Photo by Rhoda Baer The US Food and Drug Administration (FDA) has approved a supplemental new drug application for single-dose fosaprepitant...

    • Read More

    News

    Journal questions results of rivaroxaban trial

    Author:
    HT Staff
    Publish date: February 4, 2016

    An investigation by The BMJ has called into question the validity of the ROCKET AF trial, which was used to support approval for the direct oral...

    • Read More

    Pages

    • « first
    • …
    • 134
    • 135
    • 136
    • 137
    • 138
    • 139
    • 140
    • 141
    • 142
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery